Study of in vitro activity of caspofungin on non-Candida albicans yeast strains determined by two methods: M27-A2 and EUCAST;Estudio de la actividad in vitro de caspofungina sobre especies de levaduras diferentes de Candida albicans, determinada por dos métodos: M27-A2 y EUCAST

Revista Espanola de Quimioterapia

Volumn 17, Issue 3, 2004, Pages 257-262

  Romero, M ^a   Canton E ^a   Peman J ^a   Gobernado, M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Candida non albicans; Caspofungin; EUCAST; M27 A2; Minimum fungicidal concentration; Susceptibility

Indexed keywords

CASPOFUNGIN; PYRROLE;

ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; YEASTS;

EID: 9644272376     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Espinel-Ingroff, A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeast. J Clin Microbiol 1998; 36: 2950-2956.
2. Bouza, E., Munoz, P. Papel de la caspofungina en la infección fúngica. Aspectos actuelles de la infeccion fungica. Enf Infec Microbiol Clin 2002; 1: 38-42.
3. Onishi, J., Meinz, M., Thompson, J. y cols. Discovery of novel antifungal (1,3)-β-glucan syntase inhibitors. Antimicrob Agents Chemother 2000; 44: 368-377.
4. Krishnarao, T.V., Galgiani, J.N. Comparison of the in vitro activities of the echinocandin LY 303366, the pneumocandin MK-0991 and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 1997; 41: 1957-1960.
5. Bartizal, K., Gill, C.J., Abruzzo, G.K. y cols. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L743-872). Antimicrob Agents Chemother 1997; 41: 2326-2332.
6. Denning, D.W. Echinocandins and pneumocandins, a new antifungal class with a novel mode of action. J Antimicrob Chemother 1997; 40: 611-614.
7. Marco, F., Pfaller, M.A., Messer, S.A., Jones, R.N. Activity of MK-0991 (L743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp. Diagn Microbiol infect Dis 1998; 32: 33-37.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. NCCLS, Villanova, PA 1997.
9. Cuenca-Estrella, M., Moore, C.B., Barchiesi, F. y cols. AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibililv Testing (AFST-EUCAST). Clin Microbiol Infect 2003; 9: 467-474.
10. Rodríguez-Tudela, J.L., Cuenca-Estrella, M., Díaz-Guerra, T.M., Mellado, E. Standardization of antifungal susceptibility variables for a semiautoinated methodology. J Clin Microbiol 2001; 39: 2513-2517.
11. Rodríguez-Tudela, J.L., Berenguer, J., Martínez- Suárez, J.V., Sánchez, R. Comparison of a spectrophotometric method with RPM1-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M2 7-P for in vitro susceptibility testing of amphote ricin B. flucytosine and fluconazole against Candida albicans. Antimicrob Agents Chemother 1996; 40: 1998-2003.
12. Cuenca-Estrella, M., Lee-Yang, W., Ciblak. M.A. y cols. Comparative evaluation of NCCLS and EUCAST broth microdilution procedures for antifungal susceptibility testing Candida species. Antimicrob Agents Chemother 2002; 46: 3644-3647.
13. Chryssanthou, E., Cuenca-Estrella, M. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazol and caspofungin susceptibility testing of yeast species. J Clin Microbiol 2002; 40: 3841-3844.
14. Cantón, E., Pemán, J., Viudes, A., Quindós. G., Gobernado, M., Espinel-Ingroff, A. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis 2003; 45: 203-206.
15. Carrillo-Muñoz, AJ., Pemán, J., Gobernado, M. Nuevos antifúngicos. Presente y futuro. Rev Esp Quimioterap 1999; 12: 181-204.
16. Pfaller, M.A., Messer, S.A., Mills, K., Bolmstrom, A., Jones, R.N. Evaluation of E-test method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J Clin Microbiol 2001; 39: 4387-4389.
17. Moore, C.B., Oakley, K.L., Denning, D.W. In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. Clin Microbiol Infect 2001; 7: 11-16.
18. Letscher-Bru, V., Herbrecht, R. Caspofungin: The first representative of a new antifungal class. J Antimicrob Chemother 2003; 51: 513-521.
19. Pfaller, M.A., Diekema, D.J., Messer, S.A., Hollis, R.J., Jones, R.N. in vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrob Agents Chemother 2003; 47: 1068-1071.
20. Denning, D.W. Echinocandins: A new class of antifungal. J Antimicrob Chemother 2002; 49: 889-891.
21. Pfaller, M.A., Messer, S.A., Mollis, R.J., Jones, R.N., Diekema, D.J. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6970 clinical isolates of Candida spp. Antimicrob Agents Chemother 2002; 46: 1723-1727.
22. Pfaller, M.A., Messer, S.A., Boyken, L. y cols. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. J Clin Microbiol 2003; 41: 2176-2179.
23. Laverdiere, M., Restieri, C., Mabel, H. Adding 2% glucose to culture media does not influence the activity of caspofungin against Candida species. J Antimicrob Chemother 2003; 51: 183-184.
24. Ramón, M.S., Jiménez, M.T., Gobernado, M., Martinez, J.P., Cantón, E. Activiclad bactericida y efecto paradojico de fleroxacino y lomefloxacino sobre los estafilococos. Rev Esp Quimioterap 1993; 6: 75-79.
25. Cantón, E., Ramón, M.S., Jiménez, M.T., Martínez, J.P. Killing kinetics of four quinohnes against gram-positive cocci. Chemotherapy 1993; 39: 394-399.